UCHL1 was shown to be elevated in sera of patients with TNBC compared to healthy individuals, a phenomenon previously observed by Kuan et al. in exosomes isolated from TNBC cell conditioned medium and from sera of patients with aggressive breast cancer, where they further identified a correlation with doxorubicin resistance [66]. Here, UCHL1 is linked to breast carcinoma.